Providers
All 237 in CA
KEVIN T. DO, M.D.
NPI 1104078880, individual, Tustin, CA, Physical Medicine & Rehabilitation, Neuromuscular Medicine
1
Evidence tier
documented action, then payment
- Listed on the CA Medicaid exclusion list since March 7, 2003.
- Medicaid still paid claims in 22 later months, $41,061 in total.
score 95 of 100, rank 204, $41K at stake
Public list actions
Medicare revocation effective January 3, 2025, barred from re-enrolling until January 3, 2035
424.535(a)(3) felonies, Practitioner - Physical Medicine And Rehabilitation, CA
Paid after the action
Months in which Medicaid paid claims for this provider after a public action that should have triggered a screening check. This is a record of payments, not a determination that they were improper.
| list | identity check | action date | window closed | months paid after | first | last | paid after | 12 months before |
|---|---|---|---|---|---|---|---|---|
| CA Medicaid exclusion list ca medi-cal suspended & ineligible provider list (july 2026) | Exact NPI, name verified | Mar 7, 2003 | still open | 22 | Jan 2021 | Nov 2024 | $41K | $0 |
National provider registry
From the CMS NPPES Registry, refreshed daily.
| Name | KEVIN T. DO, M.D. |
| Type | Individual, sole proprietor |
| Status | Active |
| NPI issued | October 14, 2008, last updated August 16, 2023 |
| Practice location | 14161 NEWPORT AVE, Tustin, CA 92780-5161, 818-288-2757 |
| Mailing address | 14191 NEWPORT AVE., Tustin, CA 92780 |
| Specialties | Physical Medicine & Rehabilitation, Neuromuscular Medicine (2081N0008X, primary, license G76640 CA) |
Procedures billed
The specific codes behind the dollars. Medicaid figures come from T-MSIS (2018 to 2024) and are compared with every other provider billing the same code; Medicare figures come from the 2024 physician and supplier file and compare this provider's submitted charge with what Medicare allowed, against the usual ratio for that code.
Medicaid, largest codes
| code | what it is | paid | share | per patient-month | typical | rank among providers | |
|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | $18K | 45% | $157 | $836 (top 5% from $1K) | too few months to rank | |
| 95913 | Nerve conduction, 13 or more studies | $12K | 30% | $30 | $189 (top 5% from $312) | 5th percentile | |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | $2K | 5% | $7.04 | $60 (top 5% from $133) | 6th percentile | |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | $2K | 5% | $5.42 | $81 (top 5% from $202) | 4th percentile | |
| 95923 | Testing of autonomic (sympathetic) nervous system function | $2K | 4% | $30 | $59 (top 5% from $111) | too few months to rank | |
| 96132 | Evaluation of neuropsychological test, first hour | $858 | 2% | $15 | $92 (top 5% from $247) | too few months to rank | |
| 95926 | Placement of skin electrodes and measurement of stimulated sites in legs | $757 | 2% | $3.31 | too few months to rank | ||
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | $501 | 1% | $4.28 | $69 (top 5% from $140) | too few months to rank |
Medicare Part B 2024, largest codes
| code | what it is | services | beneficiaries | paid | submitted per service | allowed per service | charge to allowed | usual for this code |
|---|---|---|---|---|---|---|---|---|
| 95913 | Nerve conduction, 13 or more studies | 798 | 690 | $180K | $600 | $308 | 1.9x | 3.1x (90th percentile 6.6x) |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | 1,567 | 690 | $132K | $153 | $106 | 1.4x | 3.0x (90th percentile 6.3x) |
| 95926 | Placement of skin electrodes and measurement of stimulated sites in legs | 476 | 469 | $68K | $300 | $178 | 1.7x | 2.2x (90th percentile 22.8x) |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | 154 | 154 | $55K | $900 | $453 | 2.0x | 3.0x (90th percentile 8.4x) |
| 95925 | Placement of skin electrodes and measurement of stimulated sites in arms | 276 | 268 | $43K | $300 | $197 | 1.5x | 3.0x (90th percentile 13.0x) |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | 155 | 155 | $41K | $470 | $330 | 1.4x | 2.0x (90th percentile 3.7x) |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 292 | 113 | $26K | $151 | $112 | 1.3x | 1.6x (90th percentile 2.9x) |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 232 | 159 | $23K | $182 | $132 | 1.4x | 2.3x (90th percentile 3.8x) |
A submitted charge many times the allowed amount is common and lawful; it matters when it is far above what other providers submit for the same code.
In this area
237 providers in Orange County, CA carry an indicator in the public record, with $177.0M at stake between them. The most common is more hours than a day holds, on 117 of them, followed by part of a provider network on 111. 6 are tier 1: documented action, then payment.
| tier | provider | at stake | why |
|---|---|---|---|
| 1 | NANCY DAVIS Orange, CA, ranked 136 | $125K |
|
| 1 | RASOUL MONTAZERI Irvine, CA, ranked 213 | $35K |
|
| 1 | BRUCE HAGADORN Irvine, CA, ranked 293 | $9K |
|
| 1 | SAMPATH SURYADEVARA Anaheim, CA, ranked 349 | $3K |
|
| 1 | DUK KIM Huntington Beach, CA, ranked 391 | $1K |
|
| 1 | PAUL JOHNSON Garden Grove, CA, ranked 412 | $514 |
|
| 3 | LAGUNA HOME HEALTH SERVICES, LLC Mission Viejo, CA, ranked 924 | $4.7M |
|
| 3 | CARE DIMENSIONS LLC Huntington Beach, CA, ranked 1010 | $1.4M |
|
Recent enforcement in CA
All releasesDepartment of Justice and HHS-OIG releases for this state, newest first. Each opens in a new tab.
DOJPleaded guiltyAug 27, 2026
Anaheim Woman Pleads Guilty to Submitting More Than $2.2 Million in Fraudulent Hospice Care Claims to Medicare
Galbraith submitted approximately $2,266,694 in claims to Medicare for hospice services for beneficiaries who did not have a terminal illness with a life expectancy of six months or less, and Medicare paid her company approximately $2,140,606.
DOJCivil settlementAug 26, 2026
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. submitted claims to Medicare for skin cancer tests conducted with an unvalidated positive control range and for tests lacking sufficient patient RNA, and did not retract results or adequately refund Medicare.
DOJCivil settlementAug 26, 2026
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. billed Medicare for skin cancer tests conducted using an unvalidated positive control range and for tests with insufficient patient RNA, and did not retract the results or adequately refund Medicare.
DOJCivil settlementAug 24, 2026
Medicare Advantage Provider Monogram Health Agrees to Pay $2.4 Million to Settle False Claims Act Lawsuit
Monogram knowingly submitted diagnosis codes in four HCCs that were not clinically accurate, not supported by medical record documentation, and/or did not require or affect patient care, inflating Medicare Advantage beneficiaries' risk scores and causing CMS to make higher capitated payments to Medicare Advantage Organizations.
DOJCivil settlementAug 24, 2026
Medicare Advantage Provider Monogram Health Agrees to Pay $2.4M to Settle False Claims Act Suit
Monogram Health knowingly submitted diagnosis codes within four HCCs that were not clinically accurate, not supported by medical record documentation, and/or did not require or affect patient care, inflating Medicare Advantage beneficiaries' risk scores and causing CMS to make higher capitated payments to MAOs.
Referral packet
The packet is a draft for a reviewer. It reads every public record behind this case, states what the records show with a citation for each finding, names the regulation each finding relates to, and lists the ordinary explanations to rule out first. It never asserts intent.